Skip Navigation LinksHome > September 2011 - Volume 111 - Issue 9 > Two New Drugs for Chronic Hepatitis C
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000405053.00454.26
Drug Watch

Two New Drugs for Chronic Hepatitis C

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* Two new protease inhibitors that specifically target the hepatitis C virus have recently been approved: telaprevir (Incivek) and boceprevir (Victrelis). Both drugs are added to standard chronic hepatitis C treatment to improve the therapeutic response; they're not used as monotherapy.

* Food containing 20 g of fat must be eaten 30 minutes before taking telaprevir.

* Boceprevir can be taken just before, during, or just after a meal, with no dietary restrictions.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics